Changes
On August 30, 2022 at 8:50:25 AM UTC, Chimwemwe Mkandawire:
-
Removed tag report from Malawi Integrated HIV Program Report 2019 Q1
-
Added tag Report to Malawi Integrated HIV Program Report 2019 Q1
f | 1 | { | f | 1 | { |
2 | "author": "", | 2 | "author": "", | ||
3 | "author_email": "cmkandawire@hivmw.org", | 3 | "author_email": "cmkandawire@hivmw.org", | ||
4 | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | 4 | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | ||
n | 5 | "groups": [], | n | 5 | "groups": [ |
6 | { | ||||
7 | "description": "Group for publications", | ||||
8 | "display_name": "Publication", | ||||
9 | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | ||||
10 | "image_display_url": | ||||
11 | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | ||||
12 | "name": "publication", | ||||
13 | "title": "Publication" | ||||
14 | } | ||||
15 | ], | ||||
6 | "id": "56784023-dfdf-4958-af91-0f53d71ae584", | 16 | "id": "56784023-dfdf-4958-af91-0f53d71ae584", | ||
7 | "isopen": false, | 17 | "isopen": false, | ||
8 | "license_id": "notspecified", | 18 | "license_id": "notspecified", | ||
9 | "license_title": "License not specified", | 19 | "license_title": "License not specified", | ||
10 | "maintainer": null, | 20 | "maintainer": null, | ||
11 | "maintainer_email": null, | 21 | "maintainer_email": null, | ||
12 | "metadata_created": "2022-07-25T09:29:38.228378", | 22 | "metadata_created": "2022-07-25T09:29:38.228378", | ||
n | 13 | "metadata_modified": "2022-07-25T09:31:21.982523", | n | 23 | "metadata_modified": "2022-08-30T08:50:25.384948", |
14 | "name": "malawi-integrated-hiv-program-report-2019-q1", | 24 | "name": "malawi-integrated-hiv-program-report-2019-q1", | ||
15 | "notes": "* Scale-up of integrated HIV services had reached the | 25 | "notes": "* Scale-up of integrated HIV services had reached the | ||
16 | following number of sites:\r\n * __759__ static and __112__ | 26 | following number of sites:\r\n * __759__ static and __112__ | ||
17 | outreach HIV testing sites\r\n * __744__ (static) ART sites; 636 | 27 | outreach HIV testing sites\r\n * __744__ (static) ART sites; 636 | ||
18 | of these started at least one pregnant or breastfeeding woman and 715 | 28 | of these started at least one pregnant or breastfeeding woman and 715 | ||
19 | started symptomatic patients (Test & Treat) this quarter\r\n * | 29 | started symptomatic patients (Test & Treat) this quarter\r\n * | ||
20 | __680__ sites with HIV-exposed children in follow-up\r\n* | 30 | __680__ sites with HIV-exposed children in follow-up\r\n* | ||
21 | __1,117,587__persons were tested for HIV and received their results; | 31 | __1,117,587__persons were tested for HIV and received their results; | ||
22 | __247,550 (22%)__ accessed HIV testing for the first time; __870,037 | 32 | __247,550 (22%)__ accessed HIV testing for the first time; __870,037 | ||
23 | (78%)__ were repeat testers and __35,483 (3%)__ of these received | 33 | (78%)__ were repeat testers and __35,483 (3%)__ of these received | ||
24 | confirmatory testing (after having tested positive in the past). | 34 | confirmatory testing (after having tested positive in the past). | ||
25 | __32,313 (3%)__ clients received a positive result for the first | 35 | __32,313 (3%)__ clients received a positive result for the first | ||
26 | time1.\r\n* __22,971 (89%)__ of 24,763 blood units collected were | 36 | time1.\r\n* __22,971 (89%)__ of 24,763 blood units collected were | ||
27 | screened for (at least) HIV, hepatitis B and syphilis.\r\n* __152,908 | 37 | screened for (at least) HIV, hepatitis B and syphilis.\r\n* __152,908 | ||
28 | (98%)__ of 156,104 women at ANC had their HIV status ascertained; | 38 | (98%)__ of 156,104 women at ANC had their HIV status ascertained; | ||
29 | __10,973 (7%)__ of these were HIV positive. __129,526(95%)__ of | 39 | __10,973 (7%)__ of these were HIV positive. __129,526(95%)__ of | ||
30 | 136,653 at maternity had their HIV status ascertained __10,018(8%)__ | 40 | 136,653 at maternity had their HIV status ascertained __10,018(8%)__ | ||
31 | of these were HIV positive.\r\n* __41,868__ patients started ART this | 41 | of these were HIV positive.\r\n* __41,868__ patients started ART this | ||
32 | quarter; __79%__ were classified as asymptomatic / in WHO stage 1 and | 42 | quarter; __79%__ were classified as asymptomatic / in WHO stage 1 and | ||
33 | started under the \u201cTest & Treat\u201d policy.\r\n* __810,245__ | 43 | started under the \u201cTest & Treat\u201d policy.\r\n* __810,245__ | ||
34 | patients were alive and on ART by end of March 2019. This means that | 44 | patients were alive and on ART by end of March 2019. This means that | ||
35 | __76%__ of the estimated 1,062,622 HIV positive population was on ART. | 45 | __76%__ of the estimated 1,062,622 HIV positive population was on ART. | ||
36 | 2 ART coverage was __64%__ (44,992 / 69,987) for children3 and __77%__ | 46 | 2 ART coverage was __64%__ (44,992 / 69,987) for children3 and __77%__ | ||
37 | (765,253 / 992,635) for adults.\r\n* __76,326 (90%)__ of __85,127__ | 47 | (765,253 / 992,635) for adults.\r\n* __76,326 (90%)__ of __85,127__ | ||
38 | viral load results from routine monitoring were <1000 copies/ml. Viral | 48 | viral load results from routine monitoring were <1000 copies/ml. Viral | ||
39 | suppression rates for routine samples among children (0-14 years) and | 49 | suppression rates for routine samples among children (0-14 years) and | ||
40 | adults (15+ years) were __59%__ and __92%__, respectively.\r\n* | 50 | adults (15+ years) were __59%__ and __92%__, respectively.\r\n* | ||
41 | __74%__ of adults and __79%__ of children were retained alive on ART | 51 | __74%__ of adults and __79%__ of children were retained alive on ART | ||
42 | at 12 months after initiation.\r\n* Out of __744,835__ patients on | 52 | at 12 months after initiation.\r\n* Out of __744,835__ patients on | ||
43 | first line adult ART __427,130 (57%)__ were on TDF/3TC/EFV and | 53 | first line adult ART __427,130 (57%)__ were on TDF/3TC/EFV and | ||
44 | __284,816 (38%)__ had transitioned to TDF/3TC/DTG.\r\n* __13,000 5 | 54 | __284,816 (38%)__ had transitioned to TDF/3TC/DTG.\r\n* __13,000 5 | ||
45 | (119%)__ of an estimated 10,932 2 HIV infected pregnant women in | 55 | (119%)__ of an estimated 10,932 2 HIV infected pregnant women in | ||
46 | Malawi were on ART this quarter. __9,312(72%)__ of these were already | 56 | Malawi were on ART this quarter. __9,312(72%)__ of these were already | ||
47 | on ART when getting pregnant and __3,688 (28%)__ started ART during | 57 | on ART when getting pregnant and __3,688 (28%)__ started ART during | ||
48 | pregnancy/delivery.\r\n* An additional __1,480__ breastfeeding women | 58 | pregnancy/delivery.\r\n* An additional __1,480__ breastfeeding women | ||
49 | started ART in WHO stage 1 or 2.\r\n* __75%, 71%__ of women started | 59 | started ART in WHO stage 1 or 2.\r\n* __75%, 71%__ of women started | ||
50 | while pregnant or breastfeeding were retained on ART at 6 and 12 | 60 | while pregnant or breastfeeding were retained on ART at 6 and 12 | ||
51 | months after initiation, respectively.\r\n* __9,377 (8%)__ of infants | 61 | months after initiation, respectively.\r\n* __9,377 (8%)__ of infants | ||
52 | discharged alive from maternity were known to be HIV exposed, __9,086 | 62 | discharged alive from maternity were known to be HIV exposed, __9,086 | ||
53 | (96%)__ of these received ARV prophylaxis (nevirapine).", | 63 | (96%)__ of these received ARV prophylaxis (nevirapine).", | ||
54 | "num_resources": 1, | 64 | "num_resources": 1, | ||
55 | "num_tags": 8, | 65 | "num_tags": 8, | ||
56 | "organization": { | 66 | "organization": { | ||
57 | "approval_status": "approved", | 67 | "approval_status": "approved", | ||
58 | "created": "2021-10-14T11:02:35.234558", | 68 | "created": "2021-10-14T11:02:35.234558", | ||
59 | "description": "The Department of HIV & AIDS (DHA) was established | 69 | "description": "The Department of HIV & AIDS (DHA) was established | ||
60 | in 2001, initially as a unit in the Department of Clinical Services, | 70 | in 2001, initially as a unit in the Department of Clinical Services, | ||
61 | to coordinate the biomedical HIV Program in Malawi. The department now | 71 | to coordinate the biomedical HIV Program in Malawi. The department now | ||
62 | carries responsibility for various HIV related programs including: | 72 | carries responsibility for various HIV related programs including: | ||
63 | sexually transmitted infections (STIs), prevention of mother to child | 73 | sexually transmitted infections (STIs), prevention of mother to child | ||
64 | transmission of HIV (PMTCT), and national voluntary male medical | 74 | transmission of HIV (PMTCT), and national voluntary male medical | ||
65 | circumcision program (VMMC). All these HIV program sub-sections are | 75 | circumcision program (VMMC). All these HIV program sub-sections are | ||
66 | linked to one robust monitoring and evaluation sub-section in the HIV | 76 | linked to one robust monitoring and evaluation sub-section in the HIV | ||
67 | and AIDS Department which technically operates under the Central | 77 | and AIDS Department which technically operates under the Central | ||
68 | Monitoring and Evaluation Department (CMED) of the Ministry of | 78 | Monitoring and Evaluation Department (CMED) of the Ministry of | ||
69 | Health.", | 79 | Health.", | ||
70 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 80 | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
71 | "image_url": | 81 | "image_url": | ||
72 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | 82 | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | ||
73 | "is_organization": true, | 83 | "is_organization": true, | ||
74 | "name": "dha", | 84 | "name": "dha", | ||
75 | "state": "active", | 85 | "state": "active", | ||
76 | "title": "Department of HIV & AIDS and Viral Hepatitis", | 86 | "title": "Department of HIV & AIDS and Viral Hepatitis", | ||
77 | "type": "organization" | 87 | "type": "organization" | ||
78 | }, | 88 | }, | ||
79 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | 89 | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | ||
80 | "private": false, | 90 | "private": false, | ||
81 | "program_area": "Care and Treatment", | 91 | "program_area": "Care and Treatment", | ||
82 | "relationships_as_object": [], | 92 | "relationships_as_object": [], | ||
83 | "relationships_as_subject": [], | 93 | "relationships_as_subject": [], | ||
84 | "resources": [ | 94 | "resources": [ | ||
85 | { | 95 | { | ||
86 | "cache_last_updated": null, | 96 | "cache_last_updated": null, | ||
87 | "cache_url": null, | 97 | "cache_url": null, | ||
88 | "created": "2022-07-25T09:31:21.819031", | 98 | "created": "2022-07-25T09:31:21.819031", | ||
89 | "description": "Integrated HIV Program Report January -March | 99 | "description": "Integrated HIV Program Report January -March | ||
90 | 2019", | 100 | 2019", | ||
91 | "format": "PDF", | 101 | "format": "PDF", | ||
92 | "hash": "", | 102 | "hash": "", | ||
93 | "id": "fbf5fcf0-f68b-4016-85c5-4c7a2abc5e39", | 103 | "id": "fbf5fcf0-f68b-4016-85c5-4c7a2abc5e39", | ||
94 | "last_modified": "2022-07-25T09:31:21.775352", | 104 | "last_modified": "2022-07-25T09:31:21.775352", | ||
95 | "lfs_prefix": | 105 | "lfs_prefix": | ||
96 | "dha/malawi-integrated-hiv-program-report-2019-q1", | 106 | "dha/malawi-integrated-hiv-program-report-2019-q1", | ||
97 | "metadata_modified": "2022-07-25T09:31:21.986461", | 107 | "metadata_modified": "2022-07-25T09:31:21.986461", | ||
98 | "mimetype": "application/pdf", | 108 | "mimetype": "application/pdf", | ||
99 | "mimetype_inner": null, | 109 | "mimetype_inner": null, | ||
100 | "name": "Malawi Integrated HIV Program Report 2019 Q1", | 110 | "name": "Malawi Integrated HIV Program Report 2019 Q1", | ||
101 | "package_id": "56784023-dfdf-4958-af91-0f53d71ae584", | 111 | "package_id": "56784023-dfdf-4958-af91-0f53d71ae584", | ||
102 | "position": 0, | 112 | "position": 0, | ||
103 | "resource_type": null, | 113 | "resource_type": null, | ||
104 | "sha256": | 114 | "sha256": | ||
105 | "b9e20f0d5f25cbb93c5fd06b16ef83372c304953405c650db75d3926c38963b2", | 115 | "b9e20f0d5f25cbb93c5fd06b16ef83372c304953405c650db75d3926c38963b2", | ||
106 | "size": 4157467, | 116 | "size": 4157467, | ||
107 | "state": "active", | 117 | "state": "active", | ||
108 | "url": | 118 | "url": | ||
109 | 7a2abc5e39/download/malawi_integrated_hiv_program_report_2019-q1.pdf", | 119 | 7a2abc5e39/download/malawi_integrated_hiv_program_report_2019-q1.pdf", | ||
110 | "url_type": "upload" | 120 | "url_type": "upload" | ||
111 | } | 121 | } | ||
112 | ], | 122 | ], | ||
113 | "state": "active", | 123 | "state": "active", | ||
114 | "tags": [ | 124 | "tags": [ | ||
115 | { | 125 | { | ||
116 | "display_name": "HTC", | 126 | "display_name": "HTC", | ||
117 | "id": "6a53fcf5-e774-4295-b9c3-32da8b896f9b", | 127 | "id": "6a53fcf5-e774-4295-b9c3-32da8b896f9b", | ||
118 | "name": "HTC", | 128 | "name": "HTC", | ||
119 | "state": "active", | 129 | "state": "active", | ||
120 | "vocabulary_id": null | 130 | "vocabulary_id": null | ||
121 | }, | 131 | }, | ||
122 | { | 132 | { | ||
123 | "display_name": "PMTCT-ART", | 133 | "display_name": "PMTCT-ART", | ||
124 | "id": "83bf82ef-383c-46e2-a80c-f3431b3f99e2", | 134 | "id": "83bf82ef-383c-46e2-a80c-f3431b3f99e2", | ||
125 | "name": "PMTCT-ART", | 135 | "name": "PMTCT-ART", | ||
126 | "state": "active", | 136 | "state": "active", | ||
127 | "vocabulary_id": null | 137 | "vocabulary_id": null | ||
128 | }, | 138 | }, | ||
129 | { | 139 | { | ||
n | n | 140 | "display_name": "Report", | ||
141 | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | ||||
142 | "name": "Report", | ||||
143 | "state": "active", | ||||
144 | "vocabulary_id": null | ||||
145 | }, | ||||
146 | { | ||||
130 | "display_name": "anc", | 147 | "display_name": "anc", | ||
131 | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | 148 | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | ||
132 | "name": "anc", | 149 | "name": "anc", | ||
133 | "state": "active", | 150 | "state": "active", | ||
134 | "vocabulary_id": null | 151 | "vocabulary_id": null | ||
135 | }, | 152 | }, | ||
136 | { | 153 | { | ||
137 | "display_name": "hiv", | 154 | "display_name": "hiv", | ||
138 | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | 155 | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | ||
139 | "name": "hiv", | 156 | "name": "hiv", | ||
140 | "state": "active", | 157 | "state": "active", | ||
141 | "vocabulary_id": null | 158 | "vocabulary_id": null | ||
142 | }, | 159 | }, | ||
143 | { | 160 | { | ||
144 | "display_name": "maternity", | 161 | "display_name": "maternity", | ||
145 | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | 162 | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | ||
146 | "name": "maternity", | 163 | "name": "maternity", | ||
t | 147 | "state": "active", | t | ||
148 | "vocabulary_id": null | ||||
149 | }, | ||||
150 | { | ||||
151 | "display_name": "report", | ||||
152 | "id": "80c23033-8ff3-483d-8aa6-03e39b117372", | ||||
153 | "name": "report", | ||||
154 | "state": "active", | 164 | "state": "active", | ||
155 | "vocabulary_id": null | 165 | "vocabulary_id": null | ||
156 | }, | 166 | }, | ||
157 | { | 167 | { | ||
158 | "display_name": "sti", | 168 | "display_name": "sti", | ||
159 | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | 169 | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | ||
160 | "name": "sti", | 170 | "name": "sti", | ||
161 | "state": "active", | 171 | "state": "active", | ||
162 | "vocabulary_id": null | 172 | "vocabulary_id": null | ||
163 | }, | 173 | }, | ||
164 | { | 174 | { | ||
165 | "display_name": "viral load", | 175 | "display_name": "viral load", | ||
166 | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | 176 | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | ||
167 | "name": "viral load", | 177 | "name": "viral load", | ||
168 | "state": "active", | 178 | "state": "active", | ||
169 | "vocabulary_id": null | 179 | "vocabulary_id": null | ||
170 | } | 180 | } | ||
171 | ], | 181 | ], | ||
172 | "title": "Malawi Integrated HIV Program Report 2019 Q1", | 182 | "title": "Malawi Integrated HIV Program Report 2019 Q1", | ||
173 | "type": "dataset", | 183 | "type": "dataset", | ||
174 | "url": null, | 184 | "url": null, | ||
175 | "version": null, | 185 | "version": null, | ||
176 | "year": "2019" | 186 | "year": "2019" | ||
177 | } | 187 | } |